Boaz Lifschitz, co-founder and Managing General Partner of Peregrine Ventures. See contact routes.
Boaz Lifschitz, co-founder and Managing General Partner of Peregrine Ventures, invests across all stages from pre-seed to late-stage in life sciences, including medical devices, biotech, pharma, digital health, and esthetics. Check sizes range from a few hundred thousand dollars to $12 million for early/mid-stage deals and $10–$30 million per round for late-stage life-sciences companies. His distinctive thesis centers on Peregrine being Israel’s first dedicated healthcare VC fund, with the firm recognized as Israel’s most active healthtech investor in 2024 due to 15 strategic deals. Notable portfolio companies include Insightec, Aleph Farms, Cordio Medical, Magneto, and Momentis Surgical, with major exits such as CartiHeal, Valtech Cardio, and Neovasc totaling over $2 billion.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Or Yehuda when building a target list.
Investors like Boaz Lifschitz · Full investor directory · Investor access · Company funding database